Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of April 19, 2026

By / April 21, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

AURYXIA (ferric citrate)

Keryx biopharms Patent: 8,093,423 Expiration: Apr 21, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Strategies for Successful Biosimilar-to-Biosimilar…
The Patent Cliff Playbook: A Strategic Guide for…
Drug Formulation Stability for Business Development:…
Build a Live Drug Patent LOE Dashboard Your…
OpenAI's GPT-Rosalind = Smashed Drug Patent Cliffs…
Addressing the Challenges of Pharmaceutical…
Unlocking the Potential of Abandoned and Expired…
Mine the Orange Book: How FDA Drug Patent Data…
Patent Expiration Dates: The Calendar Every…
GPT-Rosalind: What OpenAI's Life Sciences Model…
Predict The Patent Cliff: The Patent Cliff Is…
Designing Around the Moat: A Generic Developer's…
Viagra’s Generic Cliff: Why It Wasn’t a Free-for-All
An Investor's Guide to the Biopharmaceutical Value…
How to Evaluate CDMO Performance: The Definitive…
How Financial Analysts Use Drug Patent Expiry Data…
A Pharma Exec's Guide to Preliminary…
How to Search Drug Patents: The Competitive…
Small Molecule-Biologic Combination Patents:The…
The Economics Behind Telehealth Prescription…
Using Drug Patents to Block Competitors: The Tactics…
Why the World Looks to Switzerland for…
Valuation of Pharmaceutical Companies: A…
Your Drug's Patent Expired. Now What? The Complete…

Russia’s Biosimilar Powerhouse: BIOCAD’s Patent Pipeline and the Oncology Disruption No One in the West Is Watching

Europe’s Divisional Patent Trap: How Big Pharma Delays Generics Without Ever Losing in Court

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Find Top Biopharma Talent Before Anyone Else: The Patent-to-Pipeline Hiring Playbook
Europe’s Divisional Patent Trap: How Big Pharma Delays Generics Without Ever Losing in Court
Russia’s Biosimilar Powerhouse: BIOCAD’s Patent Pipeline and the Oncology Disruption No One in the West Is Watching
Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data
Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors

Popular Posts

Russia’s Biosimilar Powerhouse: BIOCAD’s Patent Pipeline and the Oncology Disruption No One in the West Is Watching
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data
Branded Generics and Why They’re Profitable
Drug Patent Expiration: The Complete Strategic Guide to Loss of Exclusivity, Lifecycle Management, and the $400 Billion Cliff
The Patent Cliff and Beyond: A Definitive Guide to Generic and Biosimilar Market Entry
First to File. First to Profit: The Complete Guide to Paragraph IV Certifications and 180-Day Exclusivity
Germany’s Pharmaceutical Renaissance: Navigating the Future of Drug Development in Europe’s Powerhouse
The Unbundling of the Apothecary: How Vertically Integrated Telehealth Is Dismantling the Pharmaceutical Value Chain

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address